About Dalas Biotech Limited
Data last updated:
Dalas Biotech Limited is a public limited company based in Bhiwadi, Rajasthan, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 July 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1989PLC005056. Its GSTIN is 08AACCS4061Q1ZW (Rajasthan). The company holds 5 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹4.48 Cr. It was formerly known as Aimil Medicaments India Pvt Ltd and Sudman Laboratories Limited. It is led by directors including Sangita Rajani (Whole-Time Director) and Mukesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 292 RIICO Industrial Area, Bhiwadi, Rajasthan, India – 301019.
As per the financials filed for FY 2024, the company reported a revenue of ₹1,050.04 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹7.57 Cr (net margin 0.7%) and EBITDA of ₹17.01 Cr (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years and 46% over five years.
The company has about 297 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Dalas Biotech. As per MCA filings, the company has open charges of ₹28.95 Cr and satisfied charges of ₹142.12 Cr on record. Court records list 79 cases involving the company, including 48 filed by the company and 31 filed against it; 9 cases are pending. The company has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹23.42 Cr; the latest was in March 2019. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is BDR Pharmaceuticals International Private Limited with revenue of ₹1,137.31 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2022, listing 243 overdue payments to 33 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dalasbiotech.com.
Company details
Name history
Dalas Biotech has undergone 3 name changes throughout its history. The company was previously known as Aimil Medicaments India Pvt Ltd, Sudman Laboratories Limited, and Aimil Medicaments India Ltd. The current legal name is Dalas Biotech Limited.
| Company Name | Status |
|---|---|
| Dalas Biotech Limited | Current |
| Aimil Medicaments India Pvt Ltd | Previous |
| Sudman Laboratories Limited | Previous |
| Aimil Medicaments India Ltd | Previous |
Contact details
Dalas Biotech Limited's registered office is in Bhiwadi, Rajasthan. Its website is dalasbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 292 RIICO Industrial Area, Bhiwadi, Rajasthan, India – 301019
- IndustryPharma, API Manufacturers
To see the full contact details of Dalas Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Dalas Biotech operates one associated brand: Dalas Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company providing health products and community support in India. | dalasbiotech.com |
Business activity
The main business activity of Dalas Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dalas Biotech Limited, buy the company report.
Financials of Dalas Biotech Limited
FY 2024 filings availableDalas Biotech Limited reported revenue of ₹1,050.04 Cr (up 43% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 43% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dalas Biotech Limited, buy the company report.
Board of directors of Dalas Biotech Limited
Dalas Biotech has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar | Director | 15 Mar 2021 | 5 Years 7 Months | Current |
| Sangita Rajani Also directs: Lady Ziggi Spaunge LLP | Whole-Time Director | 25 Mar 2015 | 11 Years 7 Months | Current |
| Shambhu Yadav | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
| Deepika Rajani | Director | 24 Sep 2016 | 10 Years 1 Months | Current |
Peer comparison
Dalas Biotech Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BDR Pharmaceuticals International Private Limited | ₹1,137.31 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Metrochem Api Private Limited | ₹1,107 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Blue Jet Healthcare Limited | ₹1,076.24 Cr (FY 2025) | 45.0% | Navi Mumbai, Maharashtra, India | |||
| Centaur Pharmaceuticals Private Limited | ₹1,060.17 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| Dalas Biotech Limitedthis company | ₹1,050.04 Cr (FY 2024) | ₹7.57 Cr | 0.7% | 43.0% | 297 | Bhiwadi, Rajasthan, India |
| Acutaas Chemicals Limited | ₹1,023.8 Cr (FY 2025) | 41.0% | Surat, Gujarat, India | |||
| Watson Pharma Private Limited | ₹1,019.98 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Otsuka Chemical (India) Private Limited | ₹1,013.6 Cr (FY 2025) | -5.0% | New Delhi, Delhi, India | |||
| Chemspec Chemicals Private Limited | ₹974.7 Cr (FY 2025) | 0.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Dalas Biotech Limited, buy the company report.
Auditor
Dalas Biotech Limited is audited by S. SINGHAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. SINGHAL & CO. | FY 2023 | 001526C |
Shareholding
The shareholding of Dalas Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dalas Biotech Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Oct 2025 | 101174292 | Others | ₹20 Cr | Open | |
| 19 Mar 2025 | 101063130 | Others | ₹4.7 Cr | Open | |
| 27 Jan 2025 | 101040132 | Hdfc Bank Limited | ₹1.5 Cr | Open | |
| 10 Nov 2023 | 100822688 | Hdfc Bank Limited | ₹1.25 Cr | Open | |
| 27 Jun 2023 | 100760917 | Hdfc Bank Limited | ₹1.5 Cr | Open |
To see the full charge records of Dalas Biotech Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Dalas Biotech Limited has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹23.42 Cr; the latest was in March 2019.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| May 2015 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Apr 2013 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Babi Investment Limited, 3 individuals |
| Mar 2011 | Funding round | ₹18.51 Cr | Investors: 4 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Jagriti Capital Services Private Limited , Kamal Nandi Finance Private Limited, Laajree Spinning and Weaving Mills Private Limited |
To see the full deal history of Dalas Biotech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dalas Biotech Limited has 79 court cases on record: 48 filed by Dalas Biotech, 31 filed against it. 9 cases are pending and 70 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 46 | 17 | 6 |
| District courts | 31 | 12 | 3 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 79)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (CSTAY) | Filed against the company by Nikom Pharmaceutical Pvt. Ltd. | Pending |
| High Court, Rajasthan | Court case (CFA) | Filed against the company by Nikom Pharmaceutical Pvt. Ltd. | Pending |
| High Court, Rajasthan | Court case (CFA) | Filed by the company against Pharma Impex Laboratories Private Limited and 1 other | Pending |
| High Court | Court case (CMCC) | Filed by the company against Pharma Impex Laboratories Private Limited, | Disposed |
| High Court | Court case (CRES) | Filed by the company against Pharma Impex Laboratories Private Limited, and 1 other | Disposed |
To see the full case history of Dalas Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Dalas Biotech Limited was last rated by Crisil on 29 May 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 29 May 2020 |
To see the full credit ratings and regulatory alerts of Dalas Biotech Limited, buy the company report.
MSME payment delays
Dalas Biotech Limited has 10 MSME Form 1 returns on record between 2019 and 2022, listing 243 overdue payments to 33 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 33)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Dalas Biotech Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dalas Biotech Limited has a workforce of 297 employees on its EPFO records as of Aug 01, 2025, across 1 active EPFO establishment.
GST
Dalas Biotech has 5 GST registrations: 1 active and 4 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCS4061Q1ZW | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dalas Biotech Limited, buy the company report.
Recent activity
Dalas Biotech Limited has 10 board changes on record since 2010: 4 appointments and 6 cessations. The latest: Shambhu Yadav was appointed as Director on 06 Jan 2023.
35 earlier events are in the company report.
Frequently asked questions
Dalas Biotech is an active public limited company based in Bhiwadi, Rajasthan, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 July 1989 (37+ years old) and is registered under CIN U24232RJ1989PLC005056.
Dalas Biotech has 4 current directors:
- Sangita Rajani - Whole-Time Director
- Mukesh Kumar - Director
- Shambhu Yadav - Director
- Deepika Rajani - Director
The latest financial statements of Dalas Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Dalas Biotech is 08AACCS4061Q1ZW, registered in Rajasthan. The company has 5 GST registrations in all, of which 1 is active and 4 are cancelled or inactive.
The CIN (Corporate Identification Number) of Dalas Biotech is U24232RJ1989PLC005056. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dalas Biotech has 79 court cases on record: 48 filed by the company and 31 filed against it. 9 are pending. Most are in the high courts.
Dalas Biotech was incorporated on 18 July 1989, making it 37+ years old. It is registered with the Registrar of Companies, Jaipur.
Dalas Biotech has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹23.42 Cr; the latest was in March 2019.
The peers of Dalas Biotech by revenue are BDR Pharmaceuticals International Private Limited, Metrochem Api Private Limited, Blue Jet Healthcare Limited, Centaur Pharmaceuticals Private Limited, Acutaas Chemicals Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shambhu Yadav was appointed as Director on 06 Jan 2023. Vipin Kundra ceased to be Director on 30 Mar 2021. Mukesh Kumar was appointed as Director on 15 Mar 2021. Dalas Biotech has 10 board changes on record in total.
Dalas Biotech has 10 MSME Form 1 returns on record between 2019 and 2022, listing 243 overdue payments to 33 micro and small suppliers. The latest return was filed on 23 Feb 2024.
Dalas Biotech can be reached through the website dalasbiotech.com. Its registered office is in Bhiwadi, Rajasthan, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
